Weight loss medications like semaglutide can cause (typically mild) side effects in some patients
Whilst not currently licensed for PCOS in the UK, growing evidence suggests GLP-1 therapy may address both metabolic and reproductive features of this complex condition
"The complete derived amino acid sequence of human lysyl oxidase and assignment of the gene to chromosome 5 (extensive sequence homology with the murine ras recision gene)"
Our GLP-1 Meal Plan is built for that gap: portioned, macro-labeled, heat-and-eat in a few minutes, no subscription
Both of these medications work well for type II diabetics and pre-diabetic patients at controlling insulin resistance
Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society, Obesity Pillars